SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-040137
Filing Date
2014-05-20
Accepted
2014-05-19 19:45:31
Documents
13
Period of Report
2014-05-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-12968_18k.htm 8-K 30082
2 EX-99.1 a14-12968_1ex99d1.htm EX-99.1 82731
3 EX-99.2 a14-12968_1ex99d2.htm EX-99.2 178706
4 EX-99.3 a14-12968_1ex99d3.htm EX-99.3 66244
5 GRAPHIC g129681mmi001.jpg GRAPHIC 33204
6 GRAPHIC g129681mmi002.jpg GRAPHIC 2107
7 GRAPHIC g129681mmi003.jpg GRAPHIC 2234
8 GRAPHIC g129681mqi001.jpg GRAPHIC 20626
9 GRAPHIC g129681mqi002.jpg GRAPHIC 31384
10 GRAPHIC g129681mqi003.jpg GRAPHIC 2054
11 GRAPHIC g129681mqi004.jpg GRAPHIC 2003
12 GRAPHIC g129681moi001.jpg GRAPHIC 1736
13 GRAPHIC g129681moi002.jpg GRAPHIC 2178
  Complete submission text file 0001104659-14-040137.txt   494636
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 14856088
SIC: 2834 Pharmaceutical Preparations